Drug Shortage Report for SODIUM THIOSULFATE INJECTION USP
| Report ID | 209480 |
| Drug Identification Number | 02428393 |
| Brand name | SODIUM THIOSULFATE INJECTION USP |
| Common or Proper name | Sodium Thiosulfate Injection |
| Company Name | HOPE PHARMACEUTICALS LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM THIOSULFATE |
| Strength(s) | 250MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50 mL |
| ATC code | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-11-06 |
| Estimated end date | 2023-12-31 |
| Actual end date | 2024-01-08 |
| Shortage status | Resolved |
| Updated date | 2024-01-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 422 RICHARDS STREET VANCOUVER, BRITISH COLUMBIA CANADA V6B 2Z4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-01-09 | English | Compare |
| v4 | 2024-01-08 | French | Compare |
| v3 | 2024-01-08 | English | Compare |
| v2 | 2023-11-06 | French | Compare |
| v1 | 2023-11-06 | English | Compare |
Showing 1 to 5 of 5